A potential limitation of AAT is that in addition to NE, several other proteases including cathepsins and metalloproteases are also upregulated in CF/COPD which may also contribute to the lung damage but would not be blocked by AAT. Here, SERPINA1 is linked to chronic obstructive pulmonary disease.